-
Signature
-
/s/ Melodie T. Morin, Attorney-in-Fact for Stephen Williamson
-
Stock symbol
-
TMO
-
Transactions as of
-
Jul 31, 2023
-
Transactions value $
-
-$10,570,131
-
Form type
-
4
-
Date filed
-
8/2/2023, 04:33 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TMO |
Common Stock |
Options Exercise |
$2.86M |
+15K |
+54.76% |
$190.59 |
42.4K |
Jul 31, 2023 |
Direct |
|
| transaction |
TMO |
Common Stock |
Sale |
-$8.36M |
-15K |
-35.38% |
$557.42 |
27.4K |
Jul 31, 2023 |
Direct |
F1 |
| transaction |
TMO |
Common Stock |
Options Exercise |
$2.69M |
+14.1K |
+51.47% |
$190.59 |
41.5K |
Aug 1, 2023 |
Direct |
|
| transaction |
TMO |
Common Stock |
Sale |
-$7.76M |
-14.1K |
-33.98% |
$550.00 |
27.4K |
Aug 1, 2023 |
Direct |
F1 |
| holding |
TMO |
Common Stock |
|
|
|
|
|
18.7K |
Jul 31, 2023 |
By GRAT |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
TMO |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-15K |
-51.55% |
$0.00 |
14.1K |
Jul 31, 2023 |
Common Stock |
15K |
$190.59 |
Direct |
|
| transaction |
TMO |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-14.1K |
-100% |
$0.00* |
0 |
Aug 1, 2023 |
Common Stock |
14.1K |
$190.59 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: